𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Characteristics and key findings for ‘Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants’

✍ Scribed by Elvira van Dalen; Martin Offringa; Leontien Kremer


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
54 KB
Volume
1
Category
Article
ISSN
1557-6272

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

These are the characteristics and key findings for a Cochrane review, published in this issue of EBCH, first published as: Shah SS, Ohlsson A. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD004213. DOI: 10.1002/14651858.CD004213.pub2.

Further information for this Cochrane review is available in this issue of EBCH in the accompanying EBCH Summary and Expert Commentary articles. Copyright © 2006 John Wiley & Sons, Ltd.


📜 SIMILAR VOLUMES


Characteristics and key findings for ‘Ib
✍ Elvira van Dalen; Martin Offringa; Leontien Kremer 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB 👁 1 views

## Abstract These are the characteristics and key findings for a Cochrane review, published in this issue of EBCH, first published as: Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. __Cochrane Database of Systematic Re

Cochrane review: Ibuprofen for the treat
✍ Dr A Ohlsson; R Walia; S Shah 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB 👁 1 views

## Abstract ## Background A patent ductus arteriosus (PDA) complicates the clinical course of preterm infants, increasing their risks of developing chronic lung disease (CLD), necrotizing enterocolitis (NEC), and intraventricular hemorrhage (IVH). Indomethacin is used as standard therapy to close